The Supreme Court is scheduled to hear oral arguments on Tuesday, March 26, and the case will examine how mifepristone, the first drug used in two-drug abortion therapy, is used and prescribed in the United States. may have a much more significant impact.
Case, FDA vs. Hippocratic Alliance medicine, The move revolves around the U.S. Food and Drug Administration’s (FDA) reversal of safety restrictions for mifepristone, which include increasing the gestational age for babies from 7 weeks gestation to 7 weeks before a girl or woman can take the abortifacient. This includes a 2016 measure that extended the period to 10 weeks. In 2021, rules will change to allow abortionists to send mifepristone by mail. The FDA recently made permanent a rule that allows women and girls to receive prescriptions for mifepristone via telemedicine.
Alliance Defending Freedom (ADF) It has been submitted A lawsuit filed against the FDA in November 2022 on behalf of four national medical associations and several doctors alleges that the FDA “chose politics over science and approved a chemical abortion drug for use in the United States.” claims.
“The U.S. Food and Drug Administration (FDA), the federal agency responsible for ensuring the safety of the medicines Americans take, has failed women and girls,” said ADF Senior Counsel and co-counsel on the case. Eric Baptiste said at a press conference. Press conference held in Washington DC on Thursday.
Pro-abortion activists display abortion pills during an anti-abortion demonstration in New York City on March 25, 2023. (Kenna Betancur/AFP via Getty Images)
“Women need ongoing medical care when taking high-risk drugs. But in recent years, the FDA has increased the need for doctors to check for ectopic pregnancies, severe bleeding, and life-threatening infections. “They recklessly eliminated nearly every safeguard the FDA previously thought necessary for abortion pills, including in-person visits,” Baptist added. “Without a doubt, the FDA’s actions have made it less safe for women to take high-risk abortion pills.”
judge agreed In September, President Joe Biden’s Department of Justice (DOJ) Danko Laboratories LLCsells mifepristone under the brand name Mifeprex. Asked to the supreme court go backwards Lower court rulings block two FDA lawsuits that would ease restrictions on abortion pills. The Supreme Court ultimately allowed both cases to be heard and combined them into one case, allotting a total of one hour for oral arguments.
Biden’s Justice Department and the Danko Institute filed an appeal in August. ruling The 5th U.S. Circuit Court of Appeals ruled that the FDA’s 2016 decision to allow abortion pills to be taken until 10 weeks of pregnancy instead of 7 weeks was illegal. The court said the same is true of 2021 FDA rule changes that allow abortion pills to be mailed directly to patients and allow medical professionals other than doctors to prescribe mifepristone.
“In relaxing the safety restrictions for mifepristone, FDA failed to address several important concerns about whether this drug is safe for the women who use it,” the committee opinion stated. There is. written Written by Judge Jennifer Walker Elrod.
“We did not consider the cumulative impact of lifting several critical safeguards at the same time. These ‘significant’ and ‘interrelated’ changes could change the risk profile.” “Government agencies should continue to require reporting of nonfatal adverse events,” the opinion continued. “And we have not been able to gather evidence that positively indicates that mifepristone can be used safely without being directly prescribed or dispensed.”
Elrod wrote that in preparation, the plaintiffs “substantively demonstrated” that the 2016 and 2021 rule changes violate the Administrative Procedures Act (APA).
Despite the Fifth Circuit’s ruling against the government and drug companies, mifepristone remained available under existing regulations while the litigation continued.The Supreme Court took the lead paused The appeals court’s decision this spring is pending an appeal to the Supreme Court.
ADF lawsuit The agency points to six separate agency actions since the legalization of mifepristone and misoprostol in 2000. ADF claims that the agency could only approve the drug by incorrectly classifying pregnancy as a “disease.” The complaint also states that the FDA has never studied the safety of mifepristone under its labeled use conditions and ignores the potential effects of hormone-blocking therapy on the developing bodies of adolescent girls. , claims to have ignored evidence that chemical abortion drugs cause more complications than surgical abortions. , and abolished the necessary safeguards for pregnant girls and women undergoing this therapy.
A box of the drug mifepristone sits on a shelf at the West Alabama Women’s Center on March 16, 2022 in Tuscaloosa, Alabama. (AP Photo/Allen G. Breed, File)
The lawsuit details how in 2016, the FDA extended the gestational age at which a girl or woman can take abortion pills. And in 2021, the FDA allowed abortionists to send mifepristone by mail, which ADF says is “in direct violation of federal law.”
The complaint alleges the following:
All FDA actions regarding chemical abortion drugs, including their approval in 2000, major changes in 2016, approval of generic drugs in 2019, and two actions in 2021 to eliminate in-person dispensing requirements. Failed to recognize and act on federal law prohibiting it. Distribution of chemical abortion drugs by mail, carrier, or common carrier. Rather, the FDA’s actions allowed and in some cases even encouraged these illegal activities.
U.S. District Judge Matthew Kacsmalik of the Northern District of Texas issued a 67-page ruling that found the FDA’s decision illegal under federal law and issued a nationwide injunction to block abortion pills. As a result, the Fifth Circuit took up the case.
Days later, the U.S. Court of Appeals for the Fifth Circuit partially upheld the ruling. Stay The Biden Justice Department made the request.42 pages of courtroom opinion Temporarily put on hold some decisions on the 2000 FDA decision because the deadline for legal challenges may have passed, calling it a “close call” and pending additional legal arguments. He added that the court could take the opposite direction after receiving the ruling. However, the Court of Appeals denied the injunction from 2016 to the present and upheld the trial court’s injunction.
At that time, the Supreme Court put possession About the whole Kacmarik decision. As Breitbart News previously pointed out, the administrative suspension in no way reflects the legal merits of this case. Supreme Court justices can issue rulings solely to maintain the status quo while the court hears arguments from both sides.
Three members of the Women’s March group protest in support of access to abortion pills on Wednesday, March 15, 2023, in front of the federal courthouse in Amarillo, Texas. (AP Photo/David Erickson)
supreme court I refused It will take up an appeal from ADF asking the justices to rule on the legality of the FDA’s 2000 approval of mifepristone.
In medical abortion, mifepristone block The action of progesterone produced by the mother to nourish the pregnancy. When progesterone is blocked, the mother’s endometrial lining deteriorates, cutting off blood and nutrients to the developing baby, causing it to die in the mother’s womb. Next, a drug called misoprostol (also called Cytotec) causes contractions and bleeding to expel the baby from the mother’s womb.
this week. According to a report released by the pro-abortion Guttmacher Institute, medication abortions will account for 63% of all abortions performed within the U.S. formal medical system by 2023, following the Supreme Court’s reversal. It is said that Roe vs. Wade — means an estimate 642,700 fetuses died from medical abortions. This percentage is up from an estimated 53 percent in 2020 and an estimated 39 percent in 2017. The report does not include abortion pills obtained through abortion pills. National and international underground networks. This includes networks that send pills to women in red states.
The Biden administration is without mercy promotion Medication Abortion, and in January 2023, the F.D.A. approved A retail pharmacy that dispenses abortion pills. At the same time, several Democratic governors stockpiled abortion pill meanwhile enact shield law It protects health care providers who prescribe mifepristone to women and girls in states with laws protecting unborn children.
The case is FDA vs. Hippocratic Alliance Medicine, U.S. Supreme Court No. 23-235.
Katherine Hamilton is a political reporter for Breitbart News. You can follow her at @thekat_Hamilton.
